Krousel-Wood Marie, Hyre Amanda, Muntner Paul, Morisky Donald
Department of Clinical Outcomes Research, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
Curr Opin Cardiol. 2005 Jul;20(4):296-300. doi: 10.1097/01.hco.0000166597.52335.23.
Efficacious pharmacologic treatments are available for the management of hypertension, yet only about 50% of patients treated with antihypertensive medications have their blood pressure controlled. A key factor contributing to poor blood pressure control is suboptimal adherence to prescribed therapy. Despite numerous studies conducted over the last 50 years to identify the best method for increasing patient compliance, no single intervention has emerged as superior to the others. This article reviews the effectiveness of methods to improve antihypertensive medication adherence, discusses the effect of drug benefit caps on compliance, and proposes a framework for future clinical and research directions.
Several recent systematic reviews and meta-analyses have attempted to quantify the effectiveness of various methods to improve adherence. As a result of the multiple factors influencing medication adherence, a patient-centered approach that tailors interventions aimed at overcoming barriers to adherence may be necessary.
Physicians and other health care professionals should consider nonadherence to medication when evaluating a patient with poor blood pressure control. In selecting an intervention to improve compliance to medications, clinicians should consider engaging the patient in an intervention that overcomes patient-specific barriers. Future research should target development of adherence models, which simultaneously examine the effects and interactions of social, psychological, and biologic variables on antihypertensive medication adherence.
目前已有有效的药物治疗方法来管理高血压,但接受抗高血压药物治疗的患者中只有约50%的血压得到控制。导致血压控制不佳的一个关键因素是对规定治疗方案的依从性欠佳。尽管在过去50年里进行了大量研究以确定提高患者依从性的最佳方法,但没有一种干预措施被证明比其他措施更优越。本文综述了提高抗高血压药物依从性方法的有效性,讨论了药物福利上限对依从性的影响,并提出了未来临床和研究方向的框架。
最近的几项系统评价和荟萃分析试图量化各种提高依从性方法的有效性。由于影响药物依从性的因素众多,可能需要一种以患者为中心的方法,即针对克服依从性障碍量身定制干预措施。
医生和其他医疗保健专业人员在评估血压控制不佳的患者时应考虑药物不依从情况。在选择提高药物依从性的干预措施时,临床医生应考虑让患者参与一种能克服患者特定障碍的干预措施。未来的研究应致力于开发依从性模型,该模型可同时考察社会、心理和生物学变量对抗高血压药物依从性的影响及相互作用。